Samir Parekh
Professor of Medicine
Icahn School of Medicine at Mount Sinai · New York, United States
Translational researcher at Mount Sinai. Director of the Center of Excellence for Multiple Myeloma. Secondary research interest in MCL genomics, particularly SOX11 biology and epigenetic dysregulation.
SOX11 modulates BCR signaling through the PAX5/CD19 axis for therapeutic targeting in BTK-resistant mantle cell lymphoma.
Blood advances · Dec 23, 2025
The Novel Immunocompetent Eµ-SOX11CCND1 Mouse Model Phenotypically and Molecularly Resembles Human Mantle Cell Lymphoma.
Clinical cancer research : an official journal of the American Association for Cancer Research · Nov 3, 2025
CEACAM1 as a mediator of B-cell receptor signaling in mantle cell lymphoma.
Nature communications · May 29, 2025
Randomized study of induction with bendamustine-rituximab ± bortezomib and maintenance with rituximab ± lenalidomide for MCL.
Blood · Sep 5, 2024